Dischem FY HEPS rise 11.8%

Dischem came out with results today, for the year ended February. The healthcare company reported an 11.8 per cent rise in headline earnings per share. The various restrictions during each level of lockdown dramatically changed shopping behaviour and led to significant online sales growth of 260.7 per cent. The group also embarked on strategic acquisitions during the period. Rui Morais, Chief Financial Officer at Dis-Chem joins CNBC Africa for more.

Fri, 21 May 2021 17:05:38 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.